| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
9,013 |
8,664 |
$1.46M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
5,107 |
4,637 |
$1.25M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,530 |
1,359 |
$111K |
| 80053 |
Comprehensive metabolic panel |
2,208 |
1,932 |
$60K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,304 |
2,245 |
$54K |
| 36415 |
Collection of venous blood by venipuncture |
7,208 |
6,313 |
$50K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,380 |
1,128 |
$40K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
280 |
275 |
$39K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,601 |
3,357 |
$31K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,558 |
1,348 |
$22K |
| 71045 |
Radiologic examination, chest; single view |
1,849 |
1,665 |
$19K |
| 81001 |
|
1,983 |
1,796 |
$18K |
| 70450 |
Computed tomography, head or brain; without contrast material |
257 |
228 |
$15K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
45 |
39 |
$15K |
| 85027 |
|
5,224 |
4,386 |
$14K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
656 |
621 |
$9K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
99 |
90 |
$8K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
991 |
972 |
$7K |
| 86171 |
|
143 |
139 |
$7K |
| 81025 |
|
1,364 |
1,263 |
$7K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,782 |
1,563 |
$4K |
| 81003 |
|
417 |
378 |
$4K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
304 |
298 |
$4K |
| 84484 |
|
1,177 |
850 |
$4K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
631 |
534 |
$3K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
47 |
43 |
$3K |
| 83880 |
|
619 |
523 |
$3K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
369 |
298 |
$3K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
26 |
26 |
$2K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
225 |
175 |
$2K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
26 |
26 |
$2K |
| 76801 |
|
31 |
27 |
$2K |
| 83690 |
|
1,028 |
925 |
$1K |
| 71046 |
Radiologic examination, chest; 2 views |
38 |
38 |
$963.63 |
| 86850 |
|
73 |
64 |
$945.94 |
| 83655 |
|
79 |
78 |
$743.81 |
| 85014 |
|
66 |
66 |
$665.89 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
42 |
41 |
$577.39 |
| 86900 |
|
442 |
398 |
$552.02 |
| 85018 |
|
66 |
66 |
$538.25 |
| 86901 |
|
444 |
399 |
$502.80 |
| 84702 |
|
74 |
60 |
$480.32 |
| 85610 |
|
293 |
250 |
$231.67 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
147 |
133 |
$91.03 |
| 85730 |
|
127 |
110 |
$79.77 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
154 |
82 |
$74.81 |
| 80047 |
|
33 |
32 |
$25.82 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
88 |
77 |
$21.59 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
17 |
15 |
$5.95 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
16 |
15 |
$1.87 |
| A9270 |
Non-covered item or service |
66 |
42 |
$0.00 |